Search
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- January 2013
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- October 2008
- July 2008
- March 2008
- February 2008
- January 2008
- November 2002
Monthly Archives: April 2011
Email from Dr June Raine, Vigilance & Risk Management of Medicines, Medicines and Healthcare products Regulatory Agency to John Perrott (21 April 2011)
Dear Mr Perrott Thank you for your email dated 7 April 2011, sending me a link to the latest information provided by Professor Ashton. We note with interest the information contained in the supplement from Professor Ashton, however, this does … Continue reading
Posted in PERROTT
Comments Off
Email from Mary Heaton, Customer Service Centre, Department of Health to Barry Haslam (11 April 2011)
Dear Mr Haslam, Thank you for your emails of 18 (two), 19 and 20 March about the prevalence of benzodiazepine addiction. I have been asked to reply. Information on the use of drugs such as benzodiazepines, evidence regarding their effects … Continue reading
Posted in benzo, Benzodiazepines
1 Comment
Email from John Perrott to Dr June Raine, Vigilance & Risk Management of Medicines, Medicines and Healthcare products Regulatory Agency, and Anne Milton, MP, Parliamentary Under Secretary of State for Public Health, Department of Health (07 April 2011)
I have provided a link below to Professor Ashton’s latest supplement to her manual providing evidence of long-term/permanent damage caused by benzodiazepines including functional damage, intolerance to other medication even after recovery and relapse under future stress. The Ashton Manual Supplement, … Continue reading
Posted in PERROTT
Comments Off
Letter from Tracy Sutton, Customer Service Centre, Department of Health to John Perrott (04 April 2011)
Dear Mr Perrott Thank you for your letter of 11 March to Anne Milton about the licensing of Ativan (lorazepam). I have been asked to reply on Ms Milton’s behalf. As you make a number of points, I shall address … Continue reading
Posted in PERROTT
Comments Off
Email from John Perrott to Mary Heaton, Customer Service Centre, Department of Health (03 April 2011)
Dear Ms Heaton, Further to my email of 31st March 2011 I have now received a “response” to my letter regarding the drug Ativan; in his email, also of 31st March, Matthew Fluck for the Department merely referred me back to the MHRA … Continue reading
Posted in PERROTT
Comments Off
Email from Deepa Shah, Freedom of Information Team, Department of Health to John Perrott (01 April 2011)
Our ref: DE00000598273 Dear Mr Perrott Thank you for your email of 3 March to Lynwen Paddy about her response of to your complaint (our ref: 580395com). You mention that question 3 of your complaint was not addressed in the response you … Continue reading
Posted in PERROTT
Comments Off
Email from John Perrott to the Parliamentary and Health Service Ombudsman (01 April 2011)
Dear Sir/Madam, I have now exhausted the Department of Health’s internal complaints procedures. They have now informed by email that the matter is closed and that they will no longer respond to my letters (copy of email below). They have given me no … Continue reading
Posted in PERROTT
Comments Off